{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:03:07Z","timestamp":1791018187445,"version":"4.1.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2465,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1111\/j.1365-2133.2008.08785.x","type":"journal-article","created":{"date-parts":[[2008,8,20]],"date-time":"2008-08-20T09:28:17Z","timestamp":1219224497000},"page":"1275-1281","source":"Crossref","is-referenced-by-count":37,"title":["Gene expression study of<i>IL10<\/i>family genes in vitiligo skin biopsies, peripheral blood mononuclear cells and sera"],"prefix":"10.1093","volume":"159","author":[{"given":"R.","family":"R\u00e4tsep","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Karelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Reimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Raud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Silm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Vasar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"K\u00f5ks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB1","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0190-9622(96)90112-7","article-title":"Psychologic effects of vitiligo: a critical incident analysis","volume":"35","author":"Kent","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399401003362","article-title":"Immunological pathomechanisms in vitiligo","volume":"3","author":"Kemp","year":"2001","journal-title":"Expert Rev Mol Med"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0625.1993.tb00023.x","article-title":"Review of the etiopathomechanism of vitiligo: a convergence theory","volume":"2","author":"Le Poole","year":"1993","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1600-0749.2003.00126.x","article-title":"Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders","volume":"17","author":"Imokawa","year":"2004","journal-title":"Pigment Cell Res"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nri1153","article-title":"Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators","volume":"3","author":"Renauld","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB6","doi-asserted-by":"crossref","first-page":"47517","DOI":"10.1074\/jbc.M205114200","article-title":"Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions","volume":"277","author":"Parrish-Novak","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB7","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1146\/annurev.immunol.22.012703.104622","article-title":"Interleukin-10 and related cytokines and receptors","volume":"22","author":"Pestka","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB8","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0002-9440(10)63238-5","article-title":"Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions","volume":"165","author":"Gerlini","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1081\/CNV-100102550","article-title":"Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma","volume":"19","author":"Nemunaitis","year":"2001","journal-title":"Cancer Invest"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0092-8674(01)00187-8","article-title":"Interleukin 20: discovery, receptor identification, and role in epidermal function","volume":"104","author":"Blumberg","year":"2001","journal-title":"Cell"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/sj.gene.6363714","article-title":"Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10)","volume":"1","author":"Gallagher","year":"2000","journal-title":"Genes Immun"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB12","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/j.1523-1747.2003.12626.x","article-title":"Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine A or calcipotriol","volume":"121","author":"Romer","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1517\/14728222.11.5.601","article-title":"IL-19 and IL-20: two novel cytokines with importance in inflammatory diseases","volume":"11","author":"Sabat","year":"2007","journal-title":"Expert Opin Ther Targets"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB14","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/sj.onc.1205116","article-title":"The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells","volume":"21","author":"Lebedeva","year":"2002","journal-title":"Oncogene"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB15","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1200\/JCO.2002.20.4.1069","article-title":"Loss of MDA-7 expression with progression of melanoma","volume":"20","author":"Ellerhorst","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB16","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.4049\/jimmunol.168.11.5397","article-title":"Cutting edge: immune cells as sources and targets of the IL-10 family members?","volume":"168","author":"Wolk","year":"2002","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB17","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1074\/jbc.M007837200","article-title":"Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes","volume":"276","author":"Kotenko","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cytogfr.2003.10.001","article-title":"The class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions","volume":"15","author":"Langer","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB19","doi-asserted-by":"crossref","first-page":"9511","DOI":"10.1073\/pnas.171303198","article-title":"A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist","volume":"98","author":"Xu","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00000372-200404000-00004","article-title":"Inflammatory changes in vitiligo: stage I and II depigmentation","volume":"26","author":"Sharquie","year":"2004","journal-title":"Am J Dermatopathol"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB21","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1365-4632.2006.02744.x","article-title":"Increased tumor necrosis factor alpha (TNF-alpha) and interleukin 1 alpha (IL1-alpha) levels in the lesional skin of patients with nonsegmental vitiligo","volume":"45","author":"Birol","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/1523-1747.ep12289743","article-title":"Alterations in IL-6, IL-8, GM-CSF, TNF-alpha, and IFN-gamma release by peripheral mononuclear cells in patients with active vitiligo","volume":"108","author":"Yu","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1087-0024.2004.00825.x","article-title":"Autoimmune aspects of depigmentation in vitiligo","volume":"9","author":"Le Poole","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB24","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1346-8138.1997.tb02292.x","article-title":"Relationship between levels of soluble interleukin-2 receptors and the types and activity of vitiligo","volume":"24","author":"Honda","year":"1997","journal-title":"J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0923-1811(99)00029-8","article-title":"Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo","volume":"21","author":"Caixia","year":"1999","journal-title":"J Dermatol Sci"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB26","first-page":"799","article-title":"Decreased proinflammatory cytokine production by peripheral blood mononuclear cells from vitiligo patients following aspirin treatment","volume":"26","author":"Zailaie","year":"2005","journal-title":"Saudi Med J"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1034\/j.1600-0749.2002.1o049.x","article-title":"New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions","volume":"15","author":"Moretti","year":"2002","journal-title":"Pigment Cell Res"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB28","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1053\/j.gastro.2005.06.071","article-title":"Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts","volume":"129","author":"Andoh","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB29","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.4049\/jimmunol.178.9.5973","article-title":"IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn\u2019s disease","volume":"178","author":"Wolk","year":"2007","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB30","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/art.20965","article-title":"Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine","volume":"52","author":"Ikeuchi","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB32","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","article-title":"IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes","volume":"174","author":"Boniface","year":"2005","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2008.08785.x-BIB33","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J Exp Med"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2008.08785.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2008.08785.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:42:23Z","timestamp":1676382143000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/159\/6\/1275\/6641714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08785.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}